Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
8,656,316
-
Shares change
-
+209,199
-
Total reported value, excl. options
-
$69,927,146
-
Value change
-
+$1,133,626
-
Put/Call ratio
-
94%
-
Number of buys
-
36
-
Number of sells
-
-33
-
Price
-
$8.08
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2018
97 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q4 2018.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,656,316 shares
of 65,881,982 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,985,640 shares), Vanguard Group Inc (1,302,726 shares), Skylands Capital, LLC (495,850 shares), STATE STREET CORP (470,195 shares), NORTHERN TRUST CORP (353,176 shares), Allianz Asset Management GmbH (336,632 shares), GEODE CAPITAL MANAGEMENT, LLC (301,498 shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (281,903 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (278,170 shares), and Sargent Investment Group, LLC (249,430 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.